Pentazocine

Pentazocine is the primary active ingredient.Formulations may include additional components like binders, fillers, and coatings to aid administration.

Management of moderate to moderately severe pain.

Often used for postoperative pain, trauma pain, and other acute pain conditions.

Tazowin Inj 1ml (Pentazocine) is a mixed opioid agonist-antagonist. It binds to opioid receptors in the central nervous system, altering pain perception and transmission. It's partial agonist activity at mu-opioid receptors and antagonist activity at kappa-opioid receptors contributes to its analgesic effects and lower risk of respiratory depression compared to pure opioid agonists, although this is still a risk.

Store at controlled room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Dosage and frequency should always be determined by a physician based on individual needs and pain severity.

Common routes of administration include oral and intravenous.

Drowsiness

Nausea

Vomiting

Dizziness

Headache

Constipation

Lightheadedness

Respiratory depression (rare but serious)

Alcohol Consumption

Avoid alcohol consumption as it can potentiate the sedative effects of pentazocine and increase the risk of adverse reactions.



While Driving or operating Machinery

Avoid driving or operating machinery until you know how pentazocine affects you, as it can cause drowsiness and dizziness.



Pregnant & Breastfeeding Women

Use during pregnancy and breastfeeding is generally avoided unless the benefits outweigh the potential risks. Consult your doctor.



Children

Use in children should be carefully evaluated and only prescribed by a physician.



Kidney

Patients with impaired kidney function may require dosage adjustments.



Liver

Patients with impaired liver function may require dosage adjustments.

Consult your physician or pharmacist for detailed information and latest updates.

Refer to the official drug monograph from your country's regulatory authority.